Treatment of the sphere-cultured glioma cells with eckol in concentrations from 50 to 90 μM also decreased the expression of the glioma stem-like cell markers CD133, Nestin, and Musashi-1. This evidence concerns the gene MSI1 and central nervous system cancer.